Below are the most recent publications written about "Nephritis" by people in Profiles.
-
Stone HK, Mitsnefes M, Dickinson K, Burrows EK, Razzaghi H, Luna IY, Gluck CA, Dixon BP, Dharnidharka VR, Smoyer WE, Somers MJ, Flynn JT, Furth SL, Bailey C, Forrest CB, Denburg M, Nehus E. Clinical course and management of children with IgA vasculitis with nephritis. Pediatr Nephrol. 2023 11; 38(11):3721-3733.
-
Pallayova M, Mohammed A, Langman G, Taheri S, Dasgupta I. Predicting non-diabetic renal disease in type 2 diabetic adults: The value of glycated hemoglobin. J Diabetes Complications. 2015 Jul; 29(5):718-23.
-
Nagayama Y, Braun GS, Jakobs CM, Maruta Y, van Roeyen CR, Klinkhammer BM, Boor P, Villa L, Raffetseder U, Trautwein C, G?rtz D, M?ller-Newen G, Ostendorf T, Floege J. Gp130-dependent signaling in the podocyte. Am J Physiol Renal Physiol. 2014 Aug 01; 307(3):F346-55.
-
Klinkhammer BM, Kramann R, Mallau M, Makowska A, van Roeyen CR, Rong S, Buecher EB, Boor P, Kovacova K, Zok S, Denecke B, Stuettgen E, Otten S, Floege J, Kunter U. Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potential. PLoS One. 2014; 9(3):e92115.
-
Liu L, An Y, Chen M, Liu Z, Hu X, Chou E, Eisen HJ. Trends in the prevalence of hospitalization attributable to hypertensive diseases among United States adults aged 35 and older from 1980 to 2007. Am J Cardiol. 2013 Sep 01; 112(5):694-9.
-
Schaefer L. Extracellular matrix molecules: endogenous danger signals as new drug targets in kidney diseases. Curr Opin Pharmacol. 2010 Apr; 10(2):185-90.
-
Meiorin SM, Espada G, Costa CE, Tartara A, De Matteo E, Wouters C, Martin TM, Rose CD. Granulomatous nephritis associated with R334Q mutation in NOD2. J Rheumatol. 2007 Sep; 34(9):1945-7.
-
Neofytos D, Ojha A, Mookerjee B, Wagner J, Filicko J, Ferber A, Dessain S, Grosso D, Brunner J, Flomenberg N, Flomenberg P. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant. 2007 Jan; 13(1):74-81.
-
Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 2006 Aug 04; 313(5787):670-3.
-
Kaneko Y, Nimmerjahn F, Madaio MP, Ravetch JV. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med. 2006 Mar 20; 203(3):789-97.